"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals. 

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Researchers across the pond have developed and externally validated an AI model that can predict flareups of ulcerative colitis. 

The risk stratification system was put to the test in more than 3,000 cases and proved itself to be a beneficial tool in predicting future AVM rupture across multiple risk groups.

The new collaboration aims to enable providers to provide hospital-level care at home, leaning on Atrium Health’s telemedicine services and Best Buy Health’s ongoing care at home platform.

Nearly 30 experts, including nine pediatric radiologists and seven neurorads, collaborated to create the consensus statement.

By now it’s a difficult-to-dispute likelihood: AI won’t replace doctors making diagnoses, but doctors who use AI will displace doctors who don’t use AI. The hypothesis gets a fresh airing out from the vantage point of the general public.